Infection, inflammation, and stroke;Infección, inflamación e ictus cerebral

Revista Espanola de Cardiologia Suplementos

Volumn 4, Issue G, 2004, Pages

  Ameriso, Sebastián F ^a,b   Villamil, Agustina Ruiz ^a   Barreto, María Pérez ^a  

^a Instituto de Investigaciones Neurologicas Raul Carrera   (Argentina)

^b FLENI   (Argentina)

Author keywords

Atherosclerosis; Infection; Inflammation; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; AZITHROMYCIN; C REACTIVE PROTEIN; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; MACROLIDE; TUMOR NECROSIS FACTOR ALPHA; VACCINE;

ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL WALL; CAROTID ARTERY; CEREBROVASCULAR DISEASE; CHLAMYDOPHILA PNEUMONIAE; CONFERENCE PAPER; CORRELATION ANALYSIS; CYTOMEGALOVIRUS; DISEASE COURSE; DISEASE MARKER; HELICOBACTER PYLORI; HEPATITIS A VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; INFECTION; INFLAMMATION; MEASUREMENT; MICROORGANISM; OXIDATION; PATHOGENESIS; PERIODONTAL DISEASE; PROTEIN ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SERODIAGNOSIS; STROKE; VACCINATION; VASCULAR DISEASE;

EID: 33646180563     PISSN: 11313587     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)

1. Epstein F. Atherosclerosis, an inflammatory disease. N Engl J Med. 1999;340:115-26.
2. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135-43.
3. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347:1557-65.
4. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499-511.
5. Gorelick PB. Stroke prevention therapy beyond antithrombotics: unifying mechanisms in ischemic stroke pathogenesis and implications for therapy. Stroke. 2002;33:862-75.
6. Nieto FJ. Infections and atherosclerosis: new clues from an old hypothesis? Am J Epidemiol. 1998;148:937-47.
7. Mattila KJ, Valtonen VV, Nieminen MS, Asikainen S. Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke. Clin Infect Dis. 1998;26:719-34.
8. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Rippin G, et al. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation. 2002;105:15-21.
9. Pérez Barreto M, Fischberg GM, Paganini-Hill A, Lapakulchai Y, Ameriso SF, Fisher MJ. Low-dose endotoxin reduces human cerebrovascular reactivity and produces procoagulant state. Stroke. 2001;32:360.
10. Ameriso SF, Zedda C, Boczkowski J, Leiguarda RC, Serlever GE. Heme oxygenase-1 is present in H. pylori positive atherosclerotic plaques. Stroke. 2002;33:376.
11. Ameriso SF, Fridman EA, Leiguarda RC, Sevlever GE. Detection of Helicobacter pylori in human carotid atherosclerotic plaques. Stroke. 2001;32:385-91.
12. Huittinen T, Leinonen M, Tenkanen L, Virkkunen H, Manttari M, Palosuo T, et al. Synergistic effect of persistent Chlamydia pneumoniae infection, autoimmunity, and inflammation on coronary risk. Circulation. 2003;107:2566-70.
13. Higgins JP. Chlamydia pneumoniae and coronary artery disease: the antibiotic trials. Mayo Clin Proc. 2003;78:321-32.
14. Mattila KJ, Nieminen MS, Valtonen VV, Rasi VP, Kesaniemi YA, Syrjala SL, et al. Association between dental health and acute myocardial infarction. BMJ. 1989;298:779-81.
15. Macko RF, Ameriso SF, Gruber A, Griffin JH, Fernández JA, Barndt R, et al. Impairments of the protein C system and fibrinolysis in infection-associated stroke. Stroke. 1996;27:2005-11.
16. Syrjanen J, Valtonen VV, Iivanainen M, Kaste M, Huttunen JK. Preceding infection as an important risk factor for ischaemic brain infarction in young and middle aged patients. BMJ. 1988;296:1156-60.
17. Ameriso SF, Wong VL, Quismorio FP Jr, Fisher M. Immunohematologic characteristics of infection-associated cerebral infarction. Stroke. 1991;22:1004-9.
18. Grau AJ, Buggle F, Heindl S, Steichen-Wiehn C, Banerjee T, Maiwald M, et al. Recent infection as a risk factor for cerebrovascular ischemia. Stroke. 1995;26:373-9.
19. Bova IY, Bornstein NM, Korczyn AD. Acute infection as a risk factor for ischemic stroke. Stroke. 1996;27:2204-6.
20. Macko RF, Ameriso SF, Barndt R, Clough W, Weiner JM, Fisher M. Precipitants of brain infarction: roles of preceding infection/inflammation and recent psychological stress. Stroke. 1996;27:1999-2004.
21. Grau AJ, Buggle F, Becher H, Zimmermann E, Spiel M, Fent T, et al. Recent bacterial and viral infection is a risk factor for cerebrovascular ischemia: clinical and biochemical studies. Neurology. 1998;50:196-203.
22. Naghavi M, Wyde P, Litovsky S, Madjid M, Akhtar A, Naguib S, et al. Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice. Circulation. 2003;107:762-8.
23. Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among elderly. N Engl J Med. 2003;348:1322-32.
24. Naghavi M, Barlas Z, Siadaty S, Naguib S, Madjid M, Casscells W. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation. 2000;102:3039-45.
25. Lavallee P, Perchaud V, Gautier-Bertrand M, Grabli D, Amarenco P. Association between influenza vaccination and reduced risk of brain infarction. Stroke. 2002;33:513-8.
26. Gurfinkel EP, De la Fuente RL, Mendiz O, Mautner B. Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study. Circulation. 2002;105:2143-7.
27. Bainton D, Jones GR, Hole D. Influenza and ischaemic heart disease: a possible trigger for acute myocardial infarction? Int J Epidemiol. 1978;7:231-9.
28. Binder CJ, Horkko S, Dewan A, Chang MK, Kieu EP, Goodyear CS, et al. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med. 2003;9:736-43.